178 related articles for article (PubMed ID: 34387131)
1. Early Risk of Stroke in Patients Undergoing Acute Versus Elective Cardioversion for Atrial Fibrillation.
Forslund T; Braunschweig F; Holzmann MJ; Siddiqui AJ
J Am Heart Assoc; 2021 Aug; 10(16):e021716. PubMed ID: 34387131
[TBL] [Abstract][Full Text] [Related]
2. Thromboembolic and bleeding complications after elective cardioversion of atrial fibrillation: a nationwide cohort study.
Itäinen-Strömberg S; Lehto M; Halminen O; Putaala J; Haukka J; Lehtonen O; Teppo K; Mustonen P; Linna M; Hartikainen J; Airaksinen KEJ; Aro AL
Europace; 2024 Jun; 26(6):. PubMed ID: 38829189
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion.
García-Fernández A; Marín F; Roldán V; Gómez-Sansano JM; Hernández-Romero D; Valdés M; Martinez-Martinez JG; Sogorb-Garri F; Lip GY
Circ J; 2016; 80(3):605-12. PubMed ID: 26763488
[TBL] [Abstract][Full Text] [Related]
4. Adherence to oral anticoagulant treatment and risk factor assessment six months after DC-conversion of atrial fibrillation.
Kjekshus VHR; Schuster P
Scand Cardiovasc J; 2020 Jun; 54(3):179-185. PubMed ID: 31913722
[No Abstract] [Full Text] [Related]
5. Efficacy and safety of direct oral anticoagulants in patients undergoing elective electrical cardioversion: A real-world patient population.
de Heide J; de Wit A; Bhagwandien RE; Assaf A; Gros-Bisdom J; van der Meer KC; Wijchers SA; Zijlstra F; Szili-Torok T; Lenzen MJ; Yap SC
Int J Cardiol; 2021 Mar; 326():98-102. PubMed ID: 33144120
[TBL] [Abstract][Full Text] [Related]
6. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients undergoing elective cardioversion.
Itäinen S; Lehto M; Vasankari T; Mustonen P; Kotamäki M; Numminen A; Lahtela H; Bah A; Hartikainen J; Hekkala AM; Airaksinen JKE
Europace; 2018 Apr; 20(4):565-568. PubMed ID: 29016758
[TBL] [Abstract][Full Text] [Related]
7. Real-life experience with non-vitamin K antagonist oral anticoagulants versus warfarin in patients undergoing elective cardioversion of atrial fibrillation.
Itäinen-Strömberg S; Hekkala AM; Aro AL; Vasankari T; Airaksinen KEJ; Lehto M
Ann Noninvasive Electrocardiol; 2020 Sep; 25(5):e12766. PubMed ID: 32348026
[TBL] [Abstract][Full Text] [Related]
8. Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the RHYTHM-AF study).
Lip GY; Gitt AK; Le Heuzey JY; Bash LD; Morabito CJ; Bernhardt AA; Sisk CM; Chazelle F; Crijns HJ;
Am J Cardiol; 2014 Feb; 113(3):480-4. PubMed ID: 24332698
[TBL] [Abstract][Full Text] [Related]
9. Sex Differences in Oral Anticoagulation and Outcomes of Stroke and Intracranial Bleeding in Newly Diagnosed Atrial Fibrillation.
Yong CM; Tremmel JA; Lansberg MG; Fan J; Askari M; Turakhia MP
J Am Heart Assoc; 2020 May; 9(10):e015689. PubMed ID: 32394763
[TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation patients with CHA2DS2-VASc >1 benefit from oral anticoagulation prior to cardioversion.
Själander S; Svensson PJ; Friberg L
Int J Cardiol; 2016 Jul; 215():360-3. PubMed ID: 27128562
[TBL] [Abstract][Full Text] [Related]
11. The risk and timing of acute ischemic stroke after electrical cardioversion for atrial fibrillation in Taiwan: A nationwide population-based cohort study.
Huang CK; Wang JC; Chung CH; Chen SJ; Liao WI; Chien WC
Int J Cardiol; 2022 Mar; 351():55-60. PubMed ID: 34954280
[TBL] [Abstract][Full Text] [Related]
12. Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation.
Hellman T; Kiviniemi T; Nuotio I; Vasankari T; Hartikainen J; Lip GYH; Airaksinen KEJ
Thromb Res; 2017 Aug; 156():163-167. PubMed ID: 28662483
[TBL] [Abstract][Full Text] [Related]
13. Is one month treatment with dabigatran before cardioversion of atrial fibrillation sufficient to prevent thromboembolism?
Johansson AK; Juhlin T; Engdahl J; Lind S; Hagwall K; Rorsman C; Fodor E; Alenholt A; Paul Nordin A; Rosenqvist M; Frick M
Europace; 2015 Oct; 17(10):1514-7. PubMed ID: 26017466
[TBL] [Abstract][Full Text] [Related]
14. Stroke Prevention in Atrial Fibrillation: Looking Forward.
Katsanos AH; Kamel H; Healey JS; Hart RG
Circulation; 2020 Dec; 142(24):2371-2388. PubMed ID: 33315494
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation Protocol for Secondary Prevention of Acute Ischemic Stroke Associated with Nonvalvular Atrial Fibrillation.
Kimura T; Tucker A; Nakagaki A; Sugimura T; Fukuda S; Katsuno M; Fujita T; Izumi N; Suzuki N; Sako K
J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105893. PubMed ID: 34107414
[TBL] [Abstract][Full Text] [Related]
16. Findings of transoesophageal echocardiogram in appropriately anticoagulated patients with persistent atrial fibrillation prior to planned cardioversion.
Barysienė J; Žebrauskaitė A; Petrikonytė D; Marinskis G; Aidietienė S; Aidietis A
BMC Cardiovasc Disord; 2017 Feb; 17(1):67. PubMed ID: 28228120
[TBL] [Abstract][Full Text] [Related]
17. The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion.
García-Fernández A; Marín F; Roldán V; Galcerá-Jornet E; Martínez-Martínez JG; Valdés M; Sogorb F; Lip GY
Int J Cardiol; 2016 Aug; 217():42-8. PubMed ID: 27179207
[TBL] [Abstract][Full Text] [Related]
18. Incidence of MRI-detected brain lesions and neurocognitive function after electrical cardioversion in anticoagulated patients with persistent atrial fibrillation.
Bellmann B; Fiebach JB; Guttmann S; Lin T; Haeusler KG; Bathe-Peters R; Koehler L; Steffens D; Kasner M; Tscholl V; Nagel P; Roser M; Landmesser U; Rillig A
Int J Cardiol; 2017 Sep; 243():239-243. PubMed ID: 28592382
[TBL] [Abstract][Full Text] [Related]
19. Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis.
Telles-Garcia N; Dahal K; Kocherla C; Lip GYH; Reddy P; Dominic P
Int J Cardiol; 2018 Oct; 268():143-148. PubMed ID: 30041779
[TBL] [Abstract][Full Text] [Related]
20. Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy.
Hansen ML; Jepsen RM; Olesen JB; Ruwald MH; Karasoy D; Gislason GH; Hansen J; Køber L; Husted S; Torp-Pedersen C
Europace; 2015 Jan; 17(1):18-23. PubMed ID: 25231909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
